Risk of breast cancer in users of combined oestrogen-progestogen HRT compared with users of oestrogen alone

Emily Banks

doi:10.1186/bcr-2000-66653

Risk of breast cancer in users of combined oestrogen-progestogen HRT compared with users of oestrogen alone

Emily Banks^*

^*Corresponding author for this work

National Centre for Epidemiology and Population Health

Research output: Contribution to journal › Article › peer-review

Abstract

Whilst it is clear that women using menopausal hormone replacement therapy (HRT) are at an
increased risk of breast cancer, it is uncertain whether combined oestrogen-progestogen preparations
increase risk beyond that associated with oestrogen alone.

Original language	English
Article number	66653
Journal	Breast Cancer Research
Volume	2
Issue number	1
DOIs	https://doi.org/10.1186/bcr-2000-66653
Publication status	Published - 4 Feb 2000

Access to Document

10.1186/bcr-2000-66653

Cite this

@article{5e1074c52b15446e83592040c10068e7,

title = "Risk of breast cancer in users of combined oestrogen-progestogen HRT compared with users of oestrogen alone",

abstract = "Whilst it is clear that women using menopausal hormone replacement therapy (HRT) are at an increased risk of breast cancer, it is uncertain whether combined oestrogen-progestogen preparations increase risk beyond that associated with oestrogen alone.",

keywords = "Breast cancer, Hormone replacement therapy, Oestrogen, Oestrogen-progestogen",

author = "Emily Banks",

year = "2000",

month = feb,

day = "4",

doi = "10.1186/bcr-2000-66653",

language = "English",

volume = "2",

journal = "Breast Cancer Research",

issn = "1465-5411",

publisher = "BioMed Central (BMC)",

number = "1",

}

TY - JOUR

T1 - Risk of breast cancer in users of combined oestrogen-progestogen HRT compared with users of oestrogen alone

AU - Banks, Emily

PY - 2000/2/4

Y1 - 2000/2/4

N2 - Whilst it is clear that women using menopausal hormone replacement therapy (HRT) are at an increased risk of breast cancer, it is uncertain whether combined oestrogen-progestogen preparations increase risk beyond that associated with oestrogen alone.

AB - Whilst it is clear that women using menopausal hormone replacement therapy (HRT) are at an increased risk of breast cancer, it is uncertain whether combined oestrogen-progestogen preparations increase risk beyond that associated with oestrogen alone.

KW - Breast cancer

KW - Hormone replacement therapy

KW - Oestrogen

KW - Oestrogen-progestogen

UR - https://www.scopus.com/pages/publications/84974717599

U2 - 10.1186/bcr-2000-66653

DO - 10.1186/bcr-2000-66653

M3 - Article

AN - SCOPUS:84974717599

SN - 1465-5411

VL - 2

JO - Breast Cancer Research

JF - Breast Cancer Research

IS - 1

M1 - 66653

ER -

Risk of breast cancer in users of combined oestrogen-progestogen HRT compared with users of oestrogen alone

Abstract

Access to Document

Other files and links

Fingerprint

Cite this